Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Narihito, Seki
90  Ergebnisse:
Personensuche X
?
1

Transmitter release modulated by isoprenaline in the dog is..:

Narihito, Seki ; Guoliang, Zhang ; Hikaru, Suzuki
Comparative Biochemistry and Physiology Part C: Comparative Pharmacology.  96 (1990)  1 - p. 141-146 , 1990
Link: https://doi.org/10.1016/..
 
?
2

Prognostic Impact of Histologic Subtype and Divergent Diffe..:

Minato, Akinori ; Furubayashi, Nobuki ; Nagata, Yujiro...
Current Oncology.  31 (2024)  2 - p. 862-871 , 2024
Link: https://doi.org/10.3390/..
 
?
3

Bone‐modifying agents are protective for symptomatic skelet..:

Blas, Leandro ; Shiota, Masaki ; Matsumoto, Takashi...
International Journal of Urology.  30 (2023)  11 - p. 1029-1034 , 2023
Link: https://doi.org/10.1111/..
 
?
4

Effectiveness and safety of radium‐223 dichloride in patien..:

Matsumoto, Takashi ; Hori, Yoshifumi ; Shiota, Masaki...
International Journal of Urology.  30 (2022)  2 - p. 139-146 , 2022
Link: https://doi.org/10.1111/..
 
?
5

Dissociated response among multiple metastatic lesions in t..:

Negishi, Takahito ; Nakagawa, Tohru ; Nishiyama, Naotaka...
Japanese Journal of Clinical Oncology.  52 (2022)  12 - p. 1430-1435 , 2022
Link: https://doi.org/10.1093/..
 
?
6

Association Between Immune-Related Adverse Events and Effic..:

Furubayashi, Nobuki ; Minato, Akinori ; Negishi, Takahito...
Cancer Management and Research.  14 (2022)  - p. 1641-1651 , 2022
Link: https://doi.org/10.2147/..
 
?
7

The Eosinophil Changes, Efficacy and Safety of Pembrolizuma..:

Furubayashi, Nobuki ; Minato, Akinori ; Negishi, Takahito...
OncoTargets and Therapy.  15 (2022)  - p. 1321-1330 , 2022
Link: https://doi.org/10.2147/..
 
?
8

A prospective, single‐center, randomized clinical trial to ..:

Okada, Tatsunori ; Koura, Mikifumi ; Sumikawa, Ryota...
LUTS: Lower Urinary Tract Symptoms.  14 (2022)  5 - p. 373-379 , 2022
Link: https://doi.org/10.1111/..
 
?
9

Efficacy of Pembrolizumab in Patients With Variant Urotheli..:

Minato, Akinori ; Furubayashi, Nobuki ; Harada, Mirii...
Clinical Genitourinary Cancer.  20 (2022)  5 - p. 499.e1-499.e8 , 2022
Link: https://doi.org/10.1016/..
 
?
10

Efficacy and safety of cabazitaxel therapy in elderly (≥75 ..:

Matsumoto, Takashi ; Shiota, Masaki ; Nakamura, Motonobu...
Prostate International.  9 (2021)  2 - p. 96-100 , 2021
Link: https://doi.org/10.1016/..
 
?
11

The Association of Clinical Outcomes with Posttreatment Cha..:

Furubayashi, Nobuki ; Minato, Akinori ; Negishi, Takahito...
Cancer Management and Research.  13 (2021)  - p. 8049-8056 , 2021
Link: https://doi.org/10.2147/..
 
?
12

Organ-Specific Tumor Response to Pembrolizumab in Advanced ..:

Furubayashi, Nobuki ; Negishi, Takahito ; Sakamoto, Naotaka...
OncoTargets and Therapy.  14 (2021)  - p. 1981-1988 , 2021
Link: https://doi.org/10.2147/..
 
?
13

GreenLight HPS laser 120 W vs diode laser 300 W vaporizatio..:

Kobayashi, Takeshi ; Seki, Narihito ; Song, Yoo H..
LUTS: Lower Urinary Tract Symptoms.  13 (2020)  1 - p. 31-37 , 2020
Link: https://doi.org/10.1111/..
 
?
14

Efficacy and safety of 4-weekly cabazitaxel for castration-..:

Shiota, Masaki ; Nakamura, Motonobu ; Yokomizo, Akira...
Cancer Chemotherapy and Pharmacology.  84 (2019)  3 - p. 561-566 , 2019
Link: https://doi.org/10.1007/..
 
?
15

Efficacy and safety of cabazitaxel for castration-resistant..:

Shiota, Masaki ; Nakamura, Motonobu ; Yokomizo, Akira...
Medical Oncology.  36 (2019)  4 - p. , 2019
Link: https://doi.org/10.1007/..
 
1-15